delmopinol profile

delmopinol: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

ID Source	ID
PubMed CID	57337
CHEMBL ID	2104220
CHEBI ID	135122
SCHEMBL ID	120704
MeSH ID	M0199265

Synonym
79874-76-3
decapinol
decapinolum
CHEBI:135122
delmopinol
2-[3-(4-propylheptyl)morpholin-4-yl]ethanol
(rs)-2-(3-(4-propylheptyl)morpholino)ethanol
4-morpholineethanol, 3-(4-propylheptyl)-, (+-)-
delmopinol [inn]
delmopinolum [inn-latin]
delmopinolum
dt67wl708f ,
unii-dt67wl708f
(+-)-3-(4-propylheptyl)-4-morpholineethanol
delmopinol hcl
CHEMBL2104220
delmopinol [mi]
(+/-)-3-(4-propylheptyl)-4-morpholineethanol
delmopinol [who-dd]
QSFOWAYMMZCQNF-UHFFFAOYSA-N
4-(2-hydroxyethyl)-3-(4-propylheptyl)morpholine
SCHEMBL120704
FT-0700717
Q13571783
2-(3-(4-propylheptyl)morpholino)ethanol hydrochloride
2-[3-(4-propylheptyl)morpholin-4-yl]ethan-1-ol
DTXSID10868552

Research Excerpts

Overview

Delmopinol is a tertiary amine surfactant that is used to counteract dental plaque formation. It is a morpholinoethanol derivative which, in mouthrinses used in the absence of normal oral hygiene, has been shown effective in inhibition of plaque and gingivitis.

Excerpt	Reference	Relevance
"Delmopinol is a tertiary amine surfactant that is used to counteract dental plaque formation. "	( Adsorption of delmopinol at the solid/liquid interface--the role of the acid-base equilibrium. Arnebrant, T; Halthur, T; Sjödin, T; Svensson, O, 2010)	2.16
"Delmopinol is a third-generation anti-plaque agent used as a mouthwash to reduce plaque and alleviate gingivitis."	( Meta-analyses of studies of 0.2% delmopinol mouth rinse as an adjunct to gingival health and plaque control measures. Addy, M; Moran, J; Newcombe, RG, 2007)	2.06
"Delmopinol is a new surface-active agent which can reduce plaque formation and gingivitis. "	( Effects of delmopinol on antimicrobial peroxidase systems and lysozyme in vitro and in human whole saliva. Hannuksela, S; Lenander-Lumikari, M; Tenovuo, J, 1995)	2.12
"Delmopinol hydrochloride is a highly surface active substance which has been shown to reduce the amount of plaque in vitro and in vivo and the level of gingivitis in vivo. "	( In vitro interactions of delmopinol hydrochloride with salivary films adsorbed at solid/liquid interfaces. Arnebrant, T; Rundegren, J; Vassilakos, N, 1993)	2.03
"Delmopinol is a morpholinoethanol derivative which, in mouthrinses used in the absence of normal oral hygiene, has been shown effective in the inhibition of plaque and gingivitis. "	( A 6-month home-usage trial of 0.1% and 0.2% delmopinol mouthwashes (I). Effects on plaque, gingivitis, supragingival calculus and tooth staining. Addy, M; Claydon, N; Hunter, L; Kelty, E; Moran, J; Movert, R; Wade, W, 1996)	2
"Delmopinol is a new surface active anti-plaque agent that has demonstrated a low antimicrobial effect in vitro. "	( Effect of 4 days of mouth rinsing with delmopinol or chlorhexidine on the vitality of plaque bacteria. Aström, M; Hvid, EB; Johansson, M; Rundegren, J, 1992)	2
"Delmopinol is a low molecular weight surface-active compound that has been shown to be effective against dental plaque both in vitro and in vivo and against gingivitis in vivo. "	( Influence of delmopinol on bacterial zeta-potentials and on the colloidal stability of bacterial suspensions. Arnebrant, T; Hvid, EB; Petersson, L; Simonsson, T, 1991)	2.09

Effects

Delmopinol has been shown to possess plaque inhibitory activity in several previous studies. It is considered a potential agent for the chemical control of plaque.

Excerpt	Reference	Relevance
"Delmopinol has been shown to possess plaque inhibitory activity in several previous studies."	( The relative efficacy of 0.1% and 0.2% delmopinol mouthrinses in inhibiting the development of supragingival dental plaque and gingivitis in man. Abbott, DM; Gunsolley, JC; Koertge, TE; Payne, EL, 1994)	1.28
"Delmopinol has been considered as a potential agent for the chemical control of plaque. "	( A comparison of delmopinol and chlorhexidine on plaque regrowth over a 4-day period and salivary bacterial counts. Addy, M; Aström, M; Maynard, JH; Moran, J; Movert, R; Roberts, SE; Wade, WG, 1992)	2.07

Actions

Excerpt	Reference	Relevance
"Delmopinol showed 22% lower plaque index scores than placebo after 3 months (p<0.01) and 13% lower scores after 6 months."	( 6-month use of 0.2% delmopinol hydrochloride in comparison with 0.2% chlorhexidine digluconate and placebo. (I). Effect on plaque formation and gingivitis. Attström, R; Edwardsson, S; Hase, JC; Kelty, E; Kisch, J, 1998)	1.34

Treatment

Delmopinol hydrochloride treatment of the previously placebo-treated surfaces resulted in a decrease in the number of surfaces with visible plaque from 89.3% to 6% on day 14. The delmopinols-treated plaques lost 59% of their wet weight upon sonication, while the controls lost only 19%.

Excerpt	Reference	Relevance
"Delmopinol hydrochloride treatment of the previously placebo-treated surfaces resulted in a decrease in the number of surfaces with visible plaque from 89.3% on day 7 to 6% on day 14."	( Effect of local application of delmopinol hydrochloride on developing and early established supragingival plaque in humans. Attström, R; Edwardsson, S; Klinge, B; Matsson, L; Sjödin, T, 1996)	1.3
"The delmopinol-treated plaques lost 59% of their wet weight upon sonication, while the controls lost only 19%."	( Effect of delmopinol on the cohesion of glucan-containing plaque formed by Streptococcus mutans in a flow cell system. Hansson, E; Petersson, L; Rundegren, J; Simonsson, T, 1992)	1.17

Pharmacokinetics

To compare three different rinse times with delmopinol (15, 30 and 60 seconds) with respect to inhibition of plaque growth. To determine the pharmacokinetic parameters of delmop inol for these rinse times.

Excerpt	Reference	Relevance
"To compare three different rinse times with delmopinol (15, 30 and 60 seconds) with respect to inhibition of plaque growth and to determine the pharmacokinetic parameters of delmopinol for these rinse times."	( Pharmacokinetics and clinical efficacy of delmopinol in an open rinse time study in healthy volunteers. Aström, M; Ekman, I; Håkansson, J; Sjödin, T; Sparre, B, 2011)	0.89
" Plasma samples for the pharmacokinetic evaluation were also taken."	( Pharmacokinetics and clinical efficacy of delmopinol in an open rinse time study in healthy volunteers. Aström, M; Ekman, I; Håkansson, J; Sjödin, T; Sparre, B, 2011)	0.63
" Statistical analysis of the systemic exposure, in terms of the pharmacokinetic parameters AUC(12h) and C(max) showed a significant treatment effect."	( Pharmacokinetics and clinical efficacy of delmopinol in an open rinse time study in healthy volunteers. Aström, M; Ekman, I; Håkansson, J; Sjödin, T; Sparre, B, 2011)	0.63

Bioavailability

Excerpt	Reference	Relevance
" Results indicate a very low bioavailability (1-3%) due to extensive first-pass metabolism of delmopinol after oral administration."	( Pharmacokinetics of 14C-delmopinol in the healthy male volunteer. Eriksson, B; Gunnarsson, PO; Hallström, G; Ottersgård Brorsson, AK; Sjödin, T, 1998)	0.83

Dosage Studied

The aim of this study was to investigate a possible dose-response effect of delmopinol hydrochloride, on the development of plaque and on the healing of gingivitis.

Excerpt	Relevance	Reference
"The aim of this study was to investigate a possible dose-response effect of delmopinol hydrochloride, on the development of plaque and on the healing of gingivitis."	( The effect of delmopinol rinsing on dental plaque formation and gingivitis healing. Attström, R; Collaert, B; De Bruyn, H; Movert, R, 1992)	0.87
"The aim of this study was to test a possible dose-response effect of topical application of delmopinol HCl on the salivary microbiology, the healing of a pre-established experimental gingivitis, plaque development, and supragingival plaque composition."	( Short-term effect of topical application of delmopinol on salivary microbiology, plaque, and gingivitis. Aström, M; Attström, R; Collaert, B; Edwardsson, S; Hase, JC; Movert, R, 1994)	0.77

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Class	Description
morpholines	Any compound containing morpholine as part of its structure.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	0 (0.00)	18.7374
1990's	35 (60.34)	18.2507
2000's	7 (12.07)	29.6817
2010's	10 (17.24)	24.3611
2020's	6 (10.34)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Publication Type	This drug (%)	All Drugs (%)
Trials	21 (34.43%)	5.53%
Reviews	4 (6.56%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	36 (59.02%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Trials	Classes	Roles
cetylpyridinium Cetylpyridinium: Cationic bactericidal surfactant used as a topical antiseptic for skin, wounds, mucous membranes, instruments, etc.; and also as a component in mouthwash and lozenges.	5.24	3	0	pyridinium ion
erythrosine Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.	3.36	1	1
flurbiprofen Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.. flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.	2.08	1	0	fluorobiphenyl; monocarboxylic acid	antipyretic; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug
metronidazole Metronidazole: A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS.. metronidazole : A member of the class of imidazoles substituted at C-1, -2 and -5 with 2-hydroxyethyl, nitro and methyl groups respectively. It has activity against anaerobic bacteria and protozoa, and has a radiosensitising effect on hypoxic tumour cells. It may be given by mouth in tablets, or as the benzoate in an oral suspension. The hydrochloride salt can be used in intravenous infusions. Metronidazole is a prodrug and is selective for anaerobic bacteria due to their ability to intracellularly reduce the nitro group of metronidazole to give nitroso-containing intermediates. These can covalently bind to DNA, disrupting its helical structure, inducing DNA strand breaks and inhibiting bacterial nucleic acid synthesis, ultimately resulting in bacterial cell death.	2.9	1	0	C-nitro compound; imidazoles; primary alcohol	antiamoebic agent; antibacterial drug; antimicrobial agent; antiparasitic agent; antitrichomonal drug; environmental contaminant; prodrug; radiosensitizing agent; xenobiotic
propidium Propidium: Quaternary ammonium analog of ethidium; an intercalating dye with a specific affinity to certain forms of DNA and, used as diiodide, to separate them in density gradients; also forms fluorescent complexes with cholinesterase which it inhibits.	3.36	1	1	phenanthridines; quaternary ammonium ion	fluorochrome; intercalator
sanguinarine benzophenanthridine alkaloid : A specific group of isoquinoline alkaloids that occur only in higher plants and are constituents mainly of the Papaveraceae family.	4.93	2	0	alkaloid antibiotic; benzophenanthridine alkaloid; botanical anti-fungal agent
sodium fluoride [no description available]	2.1	1	0	fluoride salt	mutagen
triclosan [no description available]	4.93	2	0	aromatic ether; dichlorobenzene; monochlorobenzenes; phenols	antibacterial agent; antimalarial; drug allergen; EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitor; EC 1.5.1.3 (dihydrofolate reductase) inhibitor; fungicide; persistent organic pollutant; xenobiotic
sucrose Saccharum: A plant genus of the family POACEAE widely cultivated in the tropics for the sweet cane that is processed into sugar.	1.98	1	0	glycosyl glycoside	algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; osmolyte; Saccharomyces cerevisiae metabolite; sweetening agent
bisphenol a 4,4'-isopropylidene diphenol: stimulates proliferative responses and cytokine productions of murine spleen cells and thymus cells in vitro. bisphenol : By usage, the methylenediphenols, HOC6H4CH2C6H4OH, commonly p,p-methylenediphenol, and their substitution products (generally derived from condensation of two equivalent amounts of a phenol with an aldehyde or ketone). The term also includes analogues in the the methylene (or substituted methylene) group has been replaced by a heteroatom.. bisphenol A : A bisphenol that is 4,4'-methanediyldiphenol in which the methylene hydrogens are replaced by two methyl groups.	2.13	1	0	bisphenol	endocrine disruptor; environmental contaminant; xenobiotic; xenoestrogen
c.i. 42510 Rosaniline Dyes: Compounds that contain the triphenylmethane aniline structure found in rosaniline. Many of them have a characteristic magenta color and are used as COLORING AGENTS.. basic fuchsin : A four-component mixture of chemically related dyes comprising pararosanilin, rosanilin, magenta II and new fuchsin in varying amounts. rosanilin : A hydrochloride that is the monohydrochloride of 4-[(4-aminophenyl)(4-iminocyclohexa-2,5-dien-1-ylidene)methyl]-2-methylaniline. One of the major constituents of Basic fuchsin, together with pararosanilin, magenta II and new fuchsin.	2	1	0
durapatite Durapatite: The mineral component of bones and teeth; it has been used therapeutically as a prosthetic aid and in the prevention and treatment of osteoporosis.. hydroxylapatite : A phosphate mineral with the formula Ca5(PO4)3(OH).	2.69	3	0
fluorescein-5-isothiocyanate Fluorescein-5-isothiocyanate: Fluorescent probe capable of being conjugated to tissue and proteins. It is used as a label in fluorescent antibody staining procedures as well as protein- and amino acid-binding techniques.. fluorescein 5-isothiocyanate : The 5-isomer of fluorescein isothiocyanate. Acts as a fluorescent probe capable of being conjugated to tissue and proteins; used as a label in fluorescent antibody staining procedures as well as protein- and amino acid-binding techniques.	2.08	1	0	fluorescein isothiocyanate
l 451167 L 451167: structure given in first source	2	1	0
titanium Titanium: A dark-gray, metallic element of widespread distribution but occurring in small amounts with atomic number, 22, atomic weight, 47.867 and symbol, Ti; specific gravity, 4.5; used for fixation of fractures.	2	1	0	titanium group element atom
titanium dioxide titanium dioxide: used medically as protectant against externally caused irritation & sunlight; high concentrations of dust may cause irritation to respiratory tract; RN given refers to titanium oxide (TiO2); structure. titanium dioxide : A titanium oxide with the formula TiO2. A naturally occurring oxide sourced from ilmenite, rutile and anatase, it has a wide range of applications.	2	1	0	titanium oxides	food colouring
amoxicillin Amoxicillin: A broad-spectrum semisynthetic antibiotic similar to AMPICILLIN except that its resistance to gastric acid permits higher serum levels with oral administration.. amoxicillin : A penicillin in which the substituent at position 6 of the penam ring is a 2-amino-2-(4-hydroxyphenyl)acetamido group.	2.9	1	0	penicillin allergen; penicillin	antibacterial drug
diacetylfluorescein [no description available]	3.36	1	1
glucuronic acid Glucuronic Acid: A sugar acid formed by the oxidation of the C-6 carbon of GLUCOSE. In addition to being a key intermediate metabolite of the uronic acid pathway, glucuronic acid also plays a role in the detoxification of certain drugs and toxins by conjugating with them to form GLUCURONIDES.. D-glucuronic acid : The D-enantiomer of glucuronic acid.. D-glucopyranuronic acid : A D-glucuronic acid in cyclic pyranose form.	2.08	1	0	D-glucuronic acid	algal metabolite
listerine Listerine: hydroalcohol solution containing thymol, menthol, eucalyptol, methyl salicylate & alcohol	2.61	2	0
hypothiocyanite ion hypothiocyanite ion: structure	1.98	1	0
povidone-iodine Povidone-Iodine: An iodinated polyvinyl polymer used as topical antiseptic in surgery and for skin and mucous membrane infections, also as aerosol. The iodine may be radiolabeled for research purposes.	2.13	1	0
fructans (2->6)-beta-D-fructan : A fructan compound consisting of repeating (2->6)-beta-linked fructofuranose units.	1.98	1	0
sodium dodecyl sulfate Sodium Dodecyl Sulfate: An anionic surfactant, usually a mixture of sodium alkyl sulfates, mainly the lauryl; lowers surface tension of aqueous solutions; used as fat emulsifier, wetting agent, detergent in cosmetics, pharmaceuticals and toothpastes; also as research tool in protein biochemistry.. sodium dodecyl sulfate : An organic sodium salt that is the sodium salt of dodecyl hydrogen sulfate.	2.69	3	0	organic sodium salt	detergent; protein denaturant
chlorhexidine Chlorhexidine: A disinfectant and topical anti-infective agent used also as mouthwash to prevent oral plaque.. chlorhexidine : A bisbiguanide compound with a structure consisting of two (p-chlorophenyl)guanide units linked by a hexamethylene bridge.	10.44	18	9	biguanides; monochlorobenzenes	antibacterial agent; antiinfective agent
mocetinostat mocetinostat: undergoing phase II clinical trials for treatment of cancer. mocetinostat : A benzamide obtained by formal condensation of the carboxy group of 4-({[4-(pyridin-3-yl)pyrimidin-2-yl]amino}methyl)benzoic acid with one of the amino groups of benzene-1,2-diamine. It is an orally active and isotype-selective HDAC inhibitor which exhibits antitumour activity (IC50 = 0.15, 0.29, 1.66 and 0.59 muM for HDAC1, HDAC2, HDAC3 and HDAC11).	1.98	1	0	aminopyrimidine; benzamides; pyridines; secondary amino compound; secondary carboxamide; substituted aniline	antineoplastic agent; apoptosis inducer; autophagy inducer; cardioprotective agent; EC 3.5.1.98 (histone deacetylase) inhibitor; hepatotoxic agent
sodium hypochlorite Sodium Hypochlorite: It is used as an oxidizing and bleaching agent and as a disinfectant. (From Grant & Hackh's Chemical Dictionary, 5th ed). sodium hypochlorite : An inorganic sodium salt in which hypochlorite is the counterion. It is used as a bleaching and disinfecting agent and is commonly found in household bleach.	2.6	1	0	inorganic sodium salt	bleaching agent; disinfectant
salicylates Salicylates: The salts or esters of salicylic acids, or salicylate esters of an organic acid. Some of these have analgesic, antipyretic, and anti-inflammatory activities by inhibiting prostaglandin synthesis.. hydroxybenzoate : Any benzoate derivative carrying a single carboxylate group and at least one hydroxy substituent.. salicylates : Any salt or ester arising from reaction of the carboxy group of salicylic acid, or any ester resulting from the condensation of the phenolic hydroxy group of salicylic acid with an organic acid.. salicylate : A monohydroxybenzoate that is the conjugate base of salicylic acid.	2.61	2	0	monohydroxybenzoate	plant metabolite
muramidase Muramidase: A basic enzyme that is present in saliva, tears, egg white, and many animal fluids. It functions as an antibacterial agent. The enzyme catalyzes the hydrolysis of 1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrin. EC 3.2.1.17.	1.98	1	0

Condition	Relationship Strength	Studies	Trials
Herpes Simplex Virus Infection [description not available]	2.41	1	0
Herpes Simplex A group of acute infections caused by herpes simplex virus type 1 or type 2 that is characterized by the development of one or more small fluid-filled vesicles with a raised erythematous base on the skin or mucous membrane. It occurs as a primary infection or recurs due to a reactivation of a latent infection. (Dorland, 27th ed.)	2.41	1	0
Gingivitis Inflammation of gum tissue (GINGIVA) without loss of connective tissue.	11.11	18	14
Periimplantitis [description not available]	7.21	1	0
Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.	2.21	1	0
Mucositis, Oral [description not available]	2.21	1	0
Stomatitis INFLAMMATION of the soft tissues of the MOUTH, such as MUCOSA; PALATE; GINGIVA; and LIP.	2.21	1	0
Peri-Implantitis An inflammatory process with loss of supporting bone in the tissues surrounding functioning DENTAL IMPLANTS.	7.21	1	0
Dental Plaque A film that attaches to teeth, often causing DENTAL CARIES and GINGIVITIS. It is composed of MUCINS, secreted from salivary glands, and microorganisms.	12.03	28	17
Parodontosis [description not available]	4.26	2	0
Periodontal Diseases Pathological processes involving the PERIODONTIUM including the gum (GINGIVA), the alveolar bone (ALVEOLAR PROCESS), the DENTAL CEMENTUM, and the PERIODONTAL LIGAMENT.	4.26	2	0
Hemorrhage, Gingival [description not available]	7.04	4	3
Gingival Hemorrhage The flowing of blood from the marginal gingival area, particularly the sulcus, seen in such conditions as GINGIVITIS, marginal PERIODONTITIS, injury, and ASCORBIC ACID DEFICIENCY.	7.04	4	3
Tooth Discoloration Any change in the hue, color, or translucency of a tooth due to any cause. Restorative filling materials, drugs (both topical and systemic), pulpal necrosis, or hemorrhage may be responsible. (Jablonski, Dictionary of Dentistry, 1992, p253)	6.18	6	6
Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)	1.98	1	0
Dental Deposit [description not available]	2.68	3	0
Calculus, Dental [description not available]	4.99	3	3
Pericementitis [description not available]	2.9	1	0
Infections, Prosthesis-Related [description not available]	2.9	1	0
Periodontitis Inflammation and loss of connective tissues supporting or surrounding the teeth. This may involve any part of the PERIODONTIUM. Periodontitis is currently classified by disease progression (CHRONIC PERIODONTITIS; AGGRESSIVE PERIODONTITIS) instead of age of onset. (From 1999 International Workshop for a Classification of Periodontal Diseases and Conditions, American Academy of Periodontology)	2.9	1	0
Hypesthesia Absent or reduced sensitivity to cutaneous stimulation.	3.38	1	1
Taste Disorder, Anterior Tongue [description not available]	3.38	1	1

delmopinol

Description

Cross-References

Synonyms (27)

Research Excerpts

Overview

Effects

Actions

Treatment

Pharmacokinetics

Bioavailability

Dosage Studied

Drug Classes (1)

Research

Studies (58)

Market Indicators

Research Demand Index: 26.80

Study Types

delmopinol

Description

Cross-References

Synonyms (27)

Research Excerpts

Overview

Effects

Actions

Treatment

Pharmacokinetics

Bioavailability

Dosage Studied

Drug Classes (1)

Research

Studies (58)

Market Indicators

Research Demand Index: 26.80

Study Types

Related Drugs (29)

Related Conditions (22)